Colorectal cancer (CRC), one of the most common and deadliest diseases worldwide, poses
a great health threat and social burden. The clinical treatments of CRC encompassing …

Accumulating evidence indicates an alarming increase in the incidence of early-onset
cancers, which are diagnosed among adults under 50 years of age, in the colorectum …

Colorectal cancer (CRC) is a global health challenge, and patient education plays a crucial
role in its early detection and treatment. Despite progress in AI technology, as exemplified by …

Abstract Background Trastuzumab (Trz)-induced cardiotoxicity (TIC) is one of the most
common adverse effects of targeted anticancer agents. Although oxidative stress …

Currently, checkpoint inhibitor‐based immunotherapy has emerged as prevailing treatment
modality for diverse cancers. However, immunotherapy as a first‐line therapy has not …

Trastuzumab (Trz) is a targeted anticancer drug for human epidermal growth factor receptor
2 (HER2)-positive tumors, as Trz-induced cardiotoxicity (TIC) is commonly observed in Trz …

Peptide nucleic acids (PNA) are synthetic nucleic acid analogues with a neutral N-(2-
aminoethyl) glycine backbone. PNA possess unique physicochemical characteristics such …

Colorectal cancer is one of the most common malignant tumors in the digestive system, and
its high incidence and metastasis rate make it a terrible killer that threatens human health. In …

Simple Summary Human colorectal cancer (CRC) is a global health burden, most notably for
minority populations. While screening tools have helped improve disease detection and …

Introduction P53 is one of the most frequently mutated genes in colorectal cancer (CRC).
The present study was undertaken to provide a solid estimate of the prognostic value of p53 …